The a-glucosidase inhibitor N-methyl-i -deoxynojirimycin (MDJN) inhibits the synthesis of N-linked complex oligosaccharides in rat intestinal epithelial cells to the same extent as reported previously for 1-deoxynojirimycin (DJN) [Saunier, Kilker, Tkacz, Quaroni & Herscovics (1982) J. Biol. Chem. 257, 14155-14161]. Analysis of each of the endo-,B-N-acetylglucosaminidase H (endo H)-sensitive oligosaccharides separated by h.p.l.c. with yeast glucosidase I, which specifically removes the terminal glucose residue from oligosaccharides containing three glucose residues, and with jack-bean (Canavalia ensiformis) a-mannosidase, indicates that both inhibitors cause the accumulation of a mixture of glucosylated oligosaccharides containing one to three glucose residues and seven to nine, and even possibly six, mannose residues. About 70% of the endo H-sensitive oligosaccharides formed in the presence of MDJN contain three glucose residues, compared with only about 20% of the corresponding oligosaccharides of the DJN treated cells. It is concluded that both compounds inhibit the formation of N-linked complex oligosaccharides by interfering with the processing glucosidases. These compounds are valuable in the study of the role of oligosaccharides in glycoproteins.
to protein. This oligosaccharide precursor is then processed to yield complex, high-mannose or hybrid structures (Hubbard & Ivatt, 1981; Staneloni & Leloir, 1982) . The first stage in processing is the removal of the glucose residues under the influence of two specific glucosidases (Grinna & Robbins, 1979; Spiro et al., 1979; Elting et al., 1980; Michael & Kornfeld, 1980; Ugalde et al., 1980; Kilker et al., 1981; Saunier et al., 1982) . In previous work we showed that the glucose analogue DJN is a potent inhibitor of both glucosidases and that it greatly inhibits the formation of 75006 Paris, France. t To whom correspondence and reprint requests should be addressed.
complex N-linked oligosaccharides in intact cells Saunier et al., 1982) . More recently it was found that MDJN inhibits processing of oligosaccharides and the formation of complex chains of viral glycoproteins (Romero et al., 1983) . In the present work we compare the effects of DJN and MDJN on glycoprotein biosynthesis in intestinal epithelial cells in culture, since neither the action of these two inhibitors nor the detailed structure of the products synthesized in their presence has yet been studied under identical conditions. Both compounds inhibit processing of N-linked oligosaccharides and cause the accumulation of a mixture of high-mannose oligosaccharides containing a variable number of glucose and mannose residues. A larger proportion of the oligosaccharides formed in the presence of MDJN contain three glucose residues.
Experimental

Materials
The source of chemicals was described previously (Sasak et al., 1982; Saunier et al., 1982 (Kilker et al., 1981) , and were treated with endo H.
Labelling of cells
Confluent IEC-6 rat intestinal-epithelial cells were labelled for 24h with D-[2-3H]mannose (5-1OjiCi/ml) or with D-[6-3H]galactose (10-20 pCi/ml) in lOml of low glucose (1 g/l) Dulbecco's modified essential medium supplemented with dialysed 5% (v/v) fetal-calf serum, 50 units of penicillin/ml, 50jg of streptomycin/ml, lOpg of insulin/ml and 4mM-L-glutamine as described previously (Sasak et al., 1982; Saunier et al., 1982) . After 24h of labelling the cells were washed three times with 1Oml of Dulbecco's phosphate-buffered saline, pH 7.4. The cells were scraped from the dishes and extracted successively with chloroform/ methanol (2: 1, v/v), three times with water, twice with methanol, and finally with chloroform/methanol/water (10: 10: 3, by vol).
Fractionation of oligosaccharides
The delipidated residue was exhaustively digested with Pronase and the resulting glycopeptides were chromatographed on a column of Bio-Gel P-6, before and after treatment with endo H as described previously (Sasak et al., 1982 of 50mM-sodium acetate buffer, pH 5.0, containing 100 mM-NaCI, 0.1 mM-ZnSO4, 25 jug of cycloheximide and 25pg of chloramphenicol. Jack-bean amannosidase (2 units) was added at the beginning, and after 24 h and 48 h of incubation. The samples were boiled for 3min, centrifuged, and the supernatant was desalted through coupled columns of AG 50W (X8, H+ form, 200-400 mesh) and AGI (X8, formate form, 200-400 mesh) resin. The amannosidase treatment was repeated and the samples were subjected to h.p.l.c. as described above.
Separation of mannose and disaccharide
To resolve mannose and disaccharide formed after a-mannosidase treatment, descending paper chromatography was performed on Whatman no. 3MM paper in propan-2-ol/acetic acid/water (27:4:9, by vol.) for 30h.
Glucosidase treatment
Yeast glucosidase I was prepared as described previously (Kilker et al., 1981; Saunier et al., 1982) . Oligosaccharides obtained from h.p.l.c. were dried, resuspended in water and were desalted through coupled columns (see above). The oligosaccharides were then incubated for 8 h at 37°C in a total volume of 404ul containing I mg of bovine serum albumin/ml, 25 jug of cycloheximide, 25 jg of chloramphenicol and 25 mM-sodium EDTA previously adjusted to pH 6.8. Glucosidase I, which was eluted from DEAE-Sephadex with potassium phosphate buffer, pH6.8, was used.
Two units of enzyme as defined by Kilker et al. (1981) were added at the beginning of incubation. At the end of the incubation, the samples were boiled for 3 min, filtered and subjected to h.p.l.c. as described above. Although the enzyme preparation still contained a trace of a-mannosidase activity, the addition of EDTA completely prevented the removal of mannose residues from labelled MangGlcNAc.
Acid hydrolysis
Samples were hydrolysed with 0.5M-H2S04 for 8h at 100°C. The hydrolysates were desalted as above and were chromatographed with galactose, mannose and glucose standards on Whatman no. 3MM paper in ethyl acetate/propan-2-ol/water (65:23:12, by vol.) . Guide strips with standards were stained with AgNO3 (Trevelyan et al., 1950) .
Radioactivity on the chromatograms was determined by cutting the paper into 1 cm strips, which were then placed into radioactivity-counting vials to which O.5ml of water and 4ml of Aquassure scintillant were added.
Results and discussion
Effect of MDJN on glycopeptides
The effect of MDJN on glycoprotein biosynthesis was examined in IEC-6 cells under conditions similar to those used previously with DJN . The glycopeptides obtained by exhaustive Pronase digestion were fractionated on Bio-Gel P-6 before and after treatment with endo H to distinguish between complex and highmannose oligosaccharides. MDJN greatly decreased the incorporation of D-[2-3H]mannose into the higher-Mr glycopeptide fractions (Figs. la and I b) . These glycopeptides were not affected by endo H, whereas the elution of the lower-Mr fraction was retarded (Figs. lc and ld). These results demonstrate that the synthesis of complex oligosaccharides is greatly inhibited by MDJN. Similar inhibition was observed with concentrations of this compound between 1 and 4mM, and with cellsurface and cell-pellet components separated by mild trypsin treatment of the cells . MDJN inhibits complex-oligosaccharide formation to the same extent as DJ N, but at a lower concentration, since it was shown previously that 1 mM-DJN was much less effective . In none of the experiments with either inhibitor was protein synthesis inhibited by 
H.p.l.c. of oligosaccharides
The endo H-sensitive oligosaccharides were fractionated by h.p.l.c. with 14C-labelled oligosaccharide standards. In control cells, six labelled oligosaccharides were obtained from total glycopeptides; five of these were eluted earlier than the standard glucose-containing oligosaccharides (Fig.  2a) .
In cells incubated with DJN, at least nine labelled oligosaccharides were resolved (Fig. 2b) , and about 55% of the radioactivity was recovered in the larger oligosaccharides (I-IV). In cells treated with MDJN, nine labelled oligosaccharides were also obtained (Fig. 2c) , but as much as 80% of the radioactivity was recovered in the larger oligosaccharides (I-IV). With both inhibitors, labelled oligosaccharides corresponding in elution to standard Glc1_3Man9GlcNAc were obtained.
Labelling ofoligosaccharidesJrom D-[6-3H]galactose
When the cells were labelled for 24h with D-[6-3H]galactose, and the glycopeptides were fractionated on Bio-Gel P-6 before and after treatment with endo H, no endo H-sensitive glycopeptides were found in control cells. The glycopeptides of treated cells, however, contained a labelled fraction that was sensitive to endo H. H.p.l.c. of these oligosaccharides showed that the major oligosaccharides obtained from treated cells corresponded in elution to those obtained after D- jack-bean oa-mannosidase released 80% of the radioactivity as mannose and about 10% as disaccharide, which is probably Man(#f-+4)GlcNAc (Table 1) .
These values correspond to the results expected from ax-mannosidase treatment of non-glucosylated high-mannose oligosaccharides and indicate that the oligosaccharides in Fig. 2(a) (1) 6330 (81) 4755 (43) 6830 (43) Each one of the labelled endo H-sensitive oligosaccharides from treated cells was characterized after preparative h.p.l.c., which gave elution profiles similar to the analytical h.p.l.c. shown in Fig. 2 . Yeast glucosidase I was used to identify oligosaccharides containing three glucose residues (Fig. 3 ). This enzyme is not inhibited by the removal of mannose residues from adjacent branches on the oligosaccharides . Exhaustive treatment with jack-bean cxmannosidase, which yielded Glc3Man4GlcNAc, Glc,Man4GlcNAc and Glc,Man4GlcNAc from standard Glc3Man9GlcNAc, Glc,Man9GlcNAc and Glcl Man9GlcNAc respectively, was also used to distinguish between oligosaccharides containing a different number of glucose residues (Fig. 4) .
Fraction I (R = 1). The (Fig. 3) , and oa-mannosidase digestion yielded about 40% Glc3Man4GlcNAc and 60%
Glc,Man4GlcNAc (Fig. 4) (Fig. 3) and yielded only Glc IMan4GlcNAc on a-mannosidase treatment (Fig. 4) . This fraction therefore contains only Glc,MangGlcNAc. About 50% of its radioactivity was released as mannose after the action of cx-mannosidase.
Fraction IV (R = 0.81-0.82). This fraction had the same elution as the product of glucosidase I treatment of fraction II, i.e. Glc,Man8GlcNAc.
For MDJN-treated cells, between 70 and 75% of the radioactivity was converted into smaller oligosaccharide by glucosidase I (Fig. 3) . About 80% of the radioactivity was converted into Glc3Man4GlcNAc after oc-mannosidase treatment (Fig. 4) , thereby confirming that the major component contained three glucose residues. The rest of the radioactivity was recovered in equivalent amounts of Glc,Man4GlcNAc and Glc1 Man4GlcNAc. From these results and the fact that this fraction is eluted earlier than the standard Glcl Man9GlcNAc, it is concluded that the major oligosaccharide is Glc3Man7GlcNAc and the minor ones are probably Glc,Man8GlcNAc and GlcIMan8GlcNAc. In contrast, for DJN-treated cells only about 30% of the radioactivity was converted into smaller oligosaccharide with glucosidase I (Fig. 3) , and three major oligosaccharides were obtained after ax-mannosidase treatment, consisting of 50% Glc3Man4GlcNAc, 17% Glc,Man4GlcNAc and 33% Glc, Man4GlcNAc (Fig. 4) . In this case, therefore, the oligosaccharide fraction contains a mixture of Glc3Man7GlcNAc, Glc,Man8GlcNAc and Glc1 Man8GlcNAc. About Fig. 2(c) (Fig. 4) . From their relative elution, it is concluded that these oligosaccharides consist mostly of Glc,Man7GlcNAc and Glc,Man7GlcNAc. Furthermore, about 62-65% of the radioactivity in these fractions was released as mannose by amannosidase; this increased release indicates that a small amount of non-glucosylated oligosaccharide is also present.
Fractions VII-IX (R = 0.33-0.58). In both cases, these smaller oligosaccharides yielded a mixture of Glc,Man4GlcNAc and Glc,Man4GlcNAc after a-mannosidase treatment (Fig. 4) , suggesting the presence of glucosylated oligosaccharides containing one and two glucose residues and less than seven mannose residues. For MDJN-treated cells, about 73% of the radioactivity was released as labelled mannose by a-mannosidase, whereas for DJN-treated cells this value was increased to 90%, indicating that, in this case, a much larger proportion of the oligosaccharides in these fractions were non-glycosylated.
From the results obtained on treatment with glucosidase I and jack-bean a-mannosidase it is estimated that about 70% of the radioactivity recovered in the oligosaccharides of MDJNtreated cells contain three glucose residues, compared with only about 20% of the oligosaccharides for DJN-treated cells.
These results demonstrate that DJN and MDJN greatly inhibit N-linked complex-oligosaccharide biosynthesis by preventing the removal of glucose residues during processing of the oligosaccharides. The maximum inhibition observed with these compounds is similar, but the N-methyl derivative is effective at a lower concentration than the parent compound (1 mm versus 5mM). With both inhibitors a mixture of endo H-sensitive oligosaccharides containing one to three glucose and seven to nine mannose residues accumulate, accounting for the existence of at least nine different oligosaccharides. A small proportion of these oligosaccharides may contain only six mannose residues. These results indicate that, even in the presence of glucose, two, and possibly three, mannose residues can be removed.
The above results demonstrate that h.p.l.c. provides a resolution not attained with standard Fraction no.
gel-filtration procedures used in other studies (Datema et al., 1982; Gross et al., 1983; Pan et al., 1983; Romero et al., 1983) in which the extent of heterogeneity of the oligosaccharides formed in the presence of processing inhibitors could not be assessed. Furthermore, the use of yeast glucosidase I, which was shown previously to specifically remove the terminal glucose from oligosaccharides containing three glucose residues regardless of the number of mannose residues present , combined with that of jack-bean amannosidase, allowed the identification of oligosaccharides containing one, two and three glucose residues. It should be pointed out that, even with the resolution afforded by h.p.l.c., enzyme treatment was essential, since some of the fractions still contained a mixture of oligosaccharides. Although both inhibitors inhibit glucosidases I and II, it appears that MDJN is a more effective inhibitor of glucosidase I in vivo than is DJN, since a much larger proportion of the oligosaccharides formed in its presence contain three glucose residues. This difference probably reflects a higher sensitivity of glucosidase I to MDJN, since it was found that yeast glucosidase I was more greatly inhibited by MDJN than by DJN at concentrations between 10 and 50 uM (B. Saunier, S. JelinekKelly & A. Herscovics, unpublished work). Similarly, Hettkamp et al. (1984) found that glucosidase I in calf liver microsomes is more strongly inhibited by MDJN than by DJN.
With both inhibitors there are always residual endo H-resistant glycopeptides remaining, and a small amount of disaccharide is obtained after amannosidase treatment, indicating that some normal processing to non-glucosylated oligosaccharides is still occurring. These results may be due to incomplete inhibition of glucosidases and/or to the existence of a pathway that is not dependent on the transfer of glucosylated oligosaccharides to It is noteworthy that similar observations were made in the mutant described by Reitman et al. (1982) , in which glucosidase II activity was reduced to less than 0.3% of normal and yet significant synthesis of complex chains still occurred. Similarly, in other studies with glucosidase inhibitors (Datema et al., 1982; Gross et al., 1983; Pan et al., 1983) , the inhibition of complex-chain synthesis was not always complete.
